Belviq Cancer Recall Lawyer

Belviq Officailly Recalled By the FDA Due to Cancer Link

Belviq and Belviq XR weight loss drugs put thousands at increased risk for cancer.

The experienced attorneys at Altman-Nussbaum-Shunnarah have helped clients across the country recover over $1 billion.

Belviq weight loss drugs have been linked to cancer. You need an attorney that has the knowledge and experience in such cases.

Belviq / Belviq XR

Belviq and its extended formula Belviq XR is prescribed for weight-loss in adults with weight-related medical conditions. The drugs are manufactured by Japanese company Eisai Inc. Belviq is known as a selective serotonin 2C receptor agonist, which means it activates very specific parts of your brain that make you feel full. Less hunger leads to less eating, which leads to weight loss.

Belviq Recalled After Being Linked to Cancer

In February 2020, Belviq was offically recalled by the United States Food and Drug Administration (FDA), after a 5-year study showed convincing links to various forms of cancer. The FDA directed patients to stop taking Belviq and its extended formula variant Belviq XR immediately and dispose of leftover pills. They also issued directives to doctors to discontinue prescribing the treatment to their patients.

Certain forms of cancer were more pronounced in the FDA's findings:

• Lung Cancer
• Pancreatic Cancer
• Colorectal Cancer

Unfortunately, these three cancers rank 1st, 2nd and 4th among the deadliest, with an annual death toll totaling more than 250,000 people. The most recent FDA study noted 7.7% of people that were administered Belviq developed some form of cancer.

The Belviq recall makes the manufacturer's behavior even more egregious considering trials showed tumor growth in rats as far back as 2010, well before its approval in 2012. The manufacturer of Belviq, Eisai Inc., released a statement that they disagreed with the FDA's findings, though they agreed to a self-recall of the drug as well.